Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...

Scientists at the University of Minnesota's Hormel Institute in Austin recently published a study that looked at a drug that ...

If you or a loved one takes antipsychotics, here are five key facts about tardive dyskinesia—a common, often-overlooked ...

Dopamine doesn’t flood the brain as once believed – it fires in exact, ultra-fast bursts that target specific neurons. The ...

A finding by a McGill-led team of neuroscientists could open doors to new treatments for a range of psychiatric and ...

More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...

Intermittent fasting may help alleviate depression symptoms by targeting dopamine receptors in the brain, according to a new study published in Neurobiology of Disease. Depression is one of the most ...

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at least 400 mg of levodopa daily, tavapadon helped reduce motor ...

Neuroleptic malignant syndrome, characterized by fever, muscular rigidity, and dysautonomia, occurs with exposure to dopamine-blocking agents. Management, especially in critical care contexts, is d ...

Access free, up-to-date clinical references on dopamine receptor agonists at Healio. We aid in making confident point-of-care decisions for type 2 diabetes.

Dopamine-receptor agonists increase the levels of dopamine in the brain and help regulate movement. Dopamine is known as the because it is part of the brain’s reward system.

One was given a dopamine agonist drug beforehand, suppressing the level of dopamine in their brains; the other was given dopamine precursor L-dopa, effectively increasing their dopamine levels.